Your browser doesn't support javascript.
Interleukin-6 receptor antagonist therapy to treat SARS-CoV-2 driven inflammatory syndrome in a kidney transplant recipient.
Allam, Sridhar R; Dao, Ann; Madhrira, Machaiah M; Antiporta, Philip B; Nair, Ranjit R; Guiteau, Jacfranz J; Reyad, Ashraf I.
  • Allam SR; Tarrant Nephrology Associates/Premier Physicians Group Health, Fort Worth, Texas, USA.
  • Dao A; Medical City Fort Worth Transplant Institute, Fort Worth, Texas, USA.
  • Madhrira MM; Medical City Fort Worth Transplant Institute, Fort Worth, Texas, USA.
  • Antiporta PB; Tarrant Nephrology Associates/Premier Physicians Group Health, Fort Worth, Texas, USA.
  • Nair RR; Medical City Fort Worth Transplant Institute, Fort Worth, Texas, USA.
  • Guiteau JJ; Infectious Disease Doctors, PA, Fort Worth, Texas, USA.
  • Reyad AI; Lung & Sleep Center of North Texas, Fort Worth, Texas, USA.
Transpl Infect Dis ; 22(4): e13326, 2020 08.
Article in English | MEDLINE | ID: covidwho-767650

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Receptors, Interleukin-6 / Antibodies, Monoclonal, Humanized / Betacoronavirus Type of study: Case report / Prognostic study Limits: Aged / Female / Humans Language: English Journal: Transpl Infect Dis Journal subject: Transplantation Year: 2020 Document Type: Article Affiliation country: Tid.13326

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Receptors, Interleukin-6 / Antibodies, Monoclonal, Humanized / Betacoronavirus Type of study: Case report / Prognostic study Limits: Aged / Female / Humans Language: English Journal: Transpl Infect Dis Journal subject: Transplantation Year: 2020 Document Type: Article Affiliation country: Tid.13326